This article proposes i) an economic framework to determine whether and in what circumstances price signalling is likely to have anticompetitive effects, and ii) some thoughts on a desirable standard to be adopted by the Commission in such cases. To read more, click the link below.
Physician Groups - The Next Enforcement Frontier for Healthcare Provider Mergers?
The Federal Trade Commission’s (FTC’s) recent announcement that it will be undertaking a retrospective study of physician group consolidations may signal an...